Reagan Jarvis, Anocca CEO
After slicing and dicing TCRs for 8 years, Swedish biotech reloads to angle for a spot in crowded cell therapy space
Södertälje, Sweden, the historic home to the Astra half of AstraZeneca, may seem an unlikely place for cutting-edge R&D on T cell receptors and cell …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
